je.st
news
Home
› Transplant Genomics And Quark Pharmaceuticals Announce Discovery And Development Collaboration
Transplant Genomics And Quark Pharmaceuticals Announce Discovery And Development Collaboration
2016-04-15 03:46:09| drugdiscoveryonline Home Page
Transplant Genomics Inc. ("TGI") and Quark Pharmaceuticals, Inc. ("Quark") today announced their joint intent to pursue a discovery and development collaboration involving the use of TGI's TruGraf™ blood test in a Phase 3 clinical trial involving patients being treated for delayed graft function (DGF) with Quark's proprietary drug candidate QPI-1002.
Tags: development
collaboration
discovery
announce
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||